Top stories

View all news

29 November 2021

Joint Statement on Dose Donations of COVID-19 Vaccines to African Countries

Building on lessons learned from our collective experience with dose donations over the past several months, the African Vaccine Acquisition Trust (AVAT), the Africa Centres for Disease Control and Prevention (Africa CDC) and COVAX wish to draw…

26 November 2021

Team Europe dose-sharing: nine additional EU member-states support lower-income countries through COVAX

As part of a pledge of 500 million doses by Team Europe, eight EU Member States have donated doses of the AstraZeneca, Johnson & Johnson and Pfizer vaccines to COVAX to support lower-income economies around the world in the fight against the…

24 November 2021

Gavi and Switzerland collaborate to prioritise supply to COVAX

Switzerland becomes first country to respond to call to trade places with COVAX in manufacturers’ supply queues.

COVAX vaccine roll-out

>563 million COVAX vaccines shipped
OWP
144 participants

As of 29 Nov 2021

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

The COVID-19 vaccine race

Pre-clinical
194vaccines
are being explored in lab experiments and animals
PHASE 1
38 vaccines
are undergoing safety tests in healthy young individuals
Phase 2
44vaccines
are being tested in broader groups of people
Phase 3
39vaccines
are in large international trials to test their impact on COVID-19
IN USE
23vaccines
are currently being offered to the general population
Phase 4
10vaccines
are being monitored in the wider population after being approved

Source: WHO

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

30 November 2021

How next-generation COVID-19 vaccines could help to end the pandemic

A year ago, we had no COVID-19 vaccines, now we have many. Could the next generation of vaccines be better still?

30 November 2021

The hunt for coronavirus variants: how the new one was found and what we know so far

There's a new COVID lineage called B.1.1.529. It has a genetic profile very different from other circulating variants.

30 November 2021

There's Only One Way to Stop the Emergence of Variants Like Omicron

"This crisis is far from over, and without dramatic course correction, will go on for some time."

Supported countries

Supported Countries

Our impact

Syringe >888 million children immunised
First aid locator >15 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >230 US$ billion in economic benefits for countries (2000–2020)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Like. Follow. Share.

    Subscribe to our newsletter